Epidural tramadol for postoperative pain after Cesarean section

Area of Science:

• Anesthesiology
• Obstetrics
• Pharmacology

Background:

• Postoperative pain management after Cesarean delivery is crucial for patient recovery.
• Epidural analgesia is a common method for pain control in Cesarean sections.
• Tramadol is an opioid analgesic with potential use in epidural anesthesia.

Purpose of the Study:

• To compare the efficacy of 100 mg versus 200 mg of epidural tramadol for postoperative pain relief.
• To evaluate the analgesic effect of epidural tramadol compared to saline placebo.
• To assess side effects associated with different doses of epidural tramadol.

Main Methods:

• A randomized controlled trial involving 60 women undergoing elective Cesarean section.
• Participants were allocated to receive either 100 mg epidural tramadol, 200 mg epidural tramadol, or saline placebo.
• Pain scores and analgesic requirements were assessed over 24 hours post-surgery.

Main Results:

• Both 100 mg and 200 mg epidural tramadol significantly prolonged the time to first analgesic administration compared to placebo.
• Cumulative analgesic requirements (meperidine and diclofenac) were lower in tramadol groups versus the control group.
• No significant differences in pain scores or analgesic needs were observed between the 100 mg and 200 mg tramadol groups.

Conclusions:

• Epidural tramadol at 100 mg provides effective postoperative analgesia following Cesarean delivery.
• The 100 mg dose of epidural tramadol appears sufficient and does not necessitate higher doses for comparable efficacy.
• Adequate pain relief was achieved without significant adverse respiratory effects.